Skip to main content
TipRanks
Go Ultimate75% OFF

Kim Janda Insider Profile

4 Followers

Kim Janda, Director at Sorrento Therapeutics, holds 3.00K shares in Sorrento Therapeutics (Ticker: SRNE).

Kim Janda's Trading History

SRNE
Sorrento Therapeutics
Dec 27, 2021DirectorUninformative Buy12.00K―
SRNE
Insider Shares: 3.00K (0.00%)
DateTransactionAmountNo. of SharesPrice per ShareProfitLink to Report
Dec 27, 2021Uninformative Sell$17.64K3,000$5.88―
Dec 27, 2021Uninformative Buy$12.00K3,000$4.00―
Sep 28, 2021Uninformative Sell$339.70K42,357$8.02―
Sep 28, 2021Uninformative Buy$89.26K42,357$2.10―
Apr 15, 2021Uninformative Sell$13.24K1,900$6.97―

You May Also Like

Kim Janda insider profile FAQ

What stocks does Kim Janda hold?
Kim Janda holds: SRNE stocks.
What was Kim Janda’s latest transaction?
Kim Janda’s latest transaction was an Uninformative Buy of $12.00K.
What is Kim Janda's role in Sorrento Therapeutics?
Kim Janda's role in Sorrento Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.